title: When can nutritional therapy impact liver disease?
abstract: This article reviews the current literature regarding nutritional therapy in liver disease, with an emphasis on patients progressing to liver failure as well as surgical patients. Mechanisms of malnutrition and sarcopenia in liver failure patients as well as nutritional assessment, nutritional requirements of this patient population, and goals and methods of therapy are discussed. Additionally, recommendations for feeding, micronutrient, branched chain amino acid supplementation, and the use of pre- and probiotics are included. The impact of these methods can have on patients with advanced disease and those undergoing surgical procedures will be emphasized.
authors.affiliation: Hiram C. Polk Jr., MD Department of Surgery, University of Louisville, Louisville, KY, 40202, USA.
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Bozeman
authors.forename: Matthew V
authors.initials: MV
authors.lastname: Benns
authors.forename: Stephen A
authors.initials: SA
authors.lastname: McClave
authors.forename: Keith R
authors.initials: KR
authors.lastname: Miller
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Jones
mesh_terms: D019587:Dietary Supplements; D005526:Food, Formulated; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000178:diet therapy*; D017093:Liver Failure / Q000150:complications / Q000178:diet therapy; D018977:Micronutrients; D015596:Nutrition Assessment; D009751:Nutritional Requirements; D055948:Sarcopenia / Q000175:diagnosis / Q000178:diet therapy / Q000209:etiology
chemical_list: D018977:Micronutrients